drugset / Trial / NCT00038519
Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to study the safety and efficacy of Amprenavir/ritonavir or saquinavir/ritonavir in HIV infected patients that have failed Kaletra as their second protease inhibitor based HAART.
Timeline
- Start
- 2001-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amprenavir | Other / unclassified | — | — |
| Subject | Saquinavir | Small molecule | — | — |
| Background | Ritonavir | Other / unclassified | — | — |